Cimzia Uses
Links shared publicly online about this topic
Cimzia Sparks Rapid Improvement in Rheumatoid Arthritis Symptoms
hcplive.com — “Results of studies on rheumatoid arthritis and Cimzia, a drug already used to treat Crohn's disease, will be presented at ACR 2010.” View full resource at hcplive.com
Most Recently Shared on November 8, 2010 at 5:32 pm By:
Cimzia Sparks Rapid Improvement in Rheumatoid Arthritis Symptoms http://hcp.lv/cmIrLe
Medicine and Technology [part of HCPLive]: CIMZIA and OXO GOOD GRIPS
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: CIMZIA and OXO GOOD GRIPS” View full resource at medicineandtechnology.com
Most Recently Shared on May 22, 2009 at 12:07 am By:
FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009
drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009” View full resource at drugs.com
Most Recently Shared on August 31, 2009 at 8:40 pm By:
FDA Alert - Update: FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/SB68Y
FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)
drugs.com — “FDA Alert: Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)” View full resource at drugs.com
Most Recently Shared on August 5, 2009 at 1:04 am By:
FDA Alert - FDA Warns Tumor Necrosis Factor (TNF) Blockers May Increase Cancer Risk - http://bit.ly/xqXMR
Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)
fda.gov — “Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)” View full resource at fda.gov
Most Recently Shared on August 5, 2009 at 4:45 pm By:
FDA warns of possible connection between drugs for inflammatory disorders and cancer in kids: http://bit.ly/BvQDV
Arthritis News: Vitamin D and Sunlight Exposure Are Associated with Reduced Knee Cartilage Loss
hopkins-arthritis.org — “The U.S. Food and Drug Administration has approved the use of certolizumab pegol (which will be marketed under the trade name Cimzia) for the treatment of moderate to severe rheumatoid arthritis (RA).” View full resource at hopkins-arthritis.org
Most Recently Shared on June 23, 2009 at 8:48 pm By:
Arthritis News: Vitamin D and Sunlight Exposure Are Associated with Reduced Knee Cartilage Loss - http://bit.ly/1jeSG
Natural Herbs Can Relieve Many Painful Disorders | ThirdAge Articles
thirdage.com — “Source FieldsArticle Source: YellowBrixArticle Source Extra Info: Tulsa World Suffering from knee pain? A free pain relief kit may help. Learn More Now!” View full resource at thirdage.com
Most Recently Shared on August 25, 2009 at 7:04 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
HCPLive_Rheum
Your online destination for Rheumatology news,events,and resources
-
Joseph Kim, MD, MPH
Physician, MIT engineer, technology advocate, blogger: MedicineandTechnology.com NonClinicalJobs.com MedicalSmartphones.com MobileHealthComputing.com
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement

